Selective Sentinel Lymph Node Biopsy and Primary Systemic Therapy in Breast Cancer

Giuliano A.E. , Kirgan D.M. , Guenther J.M. , Morton D.L. : Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg, 220: 391–401, 1994.

Alex J.C. , Krag D.N. : Gamma-probe-guided localization of lymph nodes. Surg Oncol, 2: 137–144, 1993.

Albertini J.J. , Lyman G.H. , Cox C. , Yeatman T. , Balducci L. , Ku N. , Shivers S. , Berman C. , Wells K. , Rapaport D. , Shons A. , Horton J. , Greenberg H. , Nicosia S. , Clark R. , Cantor A. , Reintgen D.S. : Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA, 276: 1818–1822, 1996.

Turner R.R. , Ollila D.W. , Krasne D.L. , Giuliano A.E. : Histopathologic validation of the sentinel lymph node hypothesis for breast cancer. Ann Surg, 226: 271–278, 1997.

McMasters K.M. , Tuttle T.M. , Carlson D.J. , Brown C.M. , Noyes R.D. , Glaser R.L. , Vennekotter D.J. , Turk P.S. , Tate P.S. , Sardi A. , Cerrito P.B. , Edwards M.J. : Sentinel lymph node biopsy for breast cancer: A suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol, 18: 2560–2566, 2000.

Miltenburg D.M. , Miller C.H. , Karamlou T.B. , Brunardi F.C. : Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res, 8: 138–142, 1999.

Cody H.S. III , Fey J. , Akhurst T. , Fazzari M. , Mazumdar M. , Yeung H. , Yeh S.D. , Borgen P.I. : Complementary of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol, 8: 13–19, 2001.

Purushotham A.D. , Upponi S. , Klevesath M.B. , Bobrow L. , Millar K. , Myles J.P. , Duffy S.W. : Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol, 23: 4312–4321, 2005.

Schulze T. , Mucke J. , Markwardt J. , Schlag P.M. , Bembenek A. : Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol, 93: 109–119, 2006.

Rietman J.S. , Geertzen J.H. , Hoekstra H.J. , Baas P. , Dolsma W.V. , de Vries J. , Groothoff J.W. , Eisma W.H. , Dijkstra P.U. : Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I and II breast cancer. Eur J Surg Oncol, 32: 148–152, 2006.

Langer I. , Guller U. , Berclaz G. , Koechli O.R. , Schaer G. , Fehr M.K. , Hess T. , Oertli D. , Bronz L. , Schnarwyler B. , Wight E. , Uehlinger U. , Infanger E. , Burger D. , Zuber M. : Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery. A prospective Swiss Multicenter study on 659 patients. Ann Surg, 245: 452–461, 2007.

Filippakis G.M. , Zografos G. : Contraindications of sentinel lymph node biopsy: Are there any really? World J Surg Oncol, 5: 10–21, 2007.

Intra M. , Rotmensz N. , Mattar D. , Gentilini O.D. , Vento A. , Veronesi P. , Colleoni M. , De Cicco C. , Cassano E. , Luini A. , Veronesi U. : Unnecessary axillary node dissection in the sentinel lymph node era. Eur J Cancer, 43: 2664–2668, 2007.

Fisher B. , Bryant J. , Wolmark N. , Mamounas E. , Brown A. , Fisher E.R. , Wickerham D.L. , Begovic M. , DeCillis A. , Robidoux A. , Margolese R.G. , Cruz A.B. Jr. , Hoehn J.L. , Lees A.W. , Dimitrov N.V. , Bear H.D. : Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol, 16: 2672–2685, 1998.

Makris A. , Ponles T.J. , Ashley S.E. , Chang J. , Hickish T. , Tidy V.A. , Nash A.G. , Ford H.T. : A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol, 9: 1179–1184, 1998.

Mauriac L. , McGrogan G. , Avril A. , Durand M. , Floquet A. , Debled M. , Dilhuydy J.M. , Bonichon F. , Institut Bergonié Bordeaux Groupe Sein (IBBGS): Neo-chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS). Ann Oncol, 10: 47–52, 1999.

Jakesz R. : Comparison of pre vs postoperative chemotherapy in breast cancer patients: four-year results of Austrian Breast and Colorectal Cancer Study Group (ABCSG) Trial 7. Proc Am Soc Clin Oncol, 20: 32, 2001.

Wolmark N. , Wang J. , Mamounas E. , Bryant J. , Fisher B. : Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant breast and bowel Project B-18. J Natl Cancer Inst Monogr, 96–102, 2001.

Mieog J.S.D. , van der Hage J.A. , van de Velde C.J.H. : Preoperative chemotherapy for women with operable breast cancer. Cochrane Database of Systematic Reviews. 2007 Issue 2. Art.N°: CD005002. DOI: 10.1002/14651858.CD005002.pub2.

Ue H. , Ogawa Y. , Karina S. , Nakatani K. , Tsuzuki K. , Miyatake K. , Maeda H. , Tanaka Y. , Sasaguri S. : Sentinel lymph node detection using computed tomography lymphography is accurate alter neoadjuvant chemotherapy for breast cancer. Oncol Rep, 17: 1475–1480, 2007.

Nason K.S. , Anderson B.O. , Byrd D.R. , Dunnwald L.K. , Eary J.F. , Mankoff D.A. , Livingston R. , Schmidt R.A. , Jewell K.D. , Yeung R.S. , Moe R.E. : Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer, 89: 2187–2194, 2000.

Fernández A. , Cortes M. , Benito E. , Azpeitia D. , Prieto L. , Moreno A. , Ricart Y. , Mora J. , Escobedo A. , Martín Comín J. : Gamma probe sentinel node localization and biopsyinbreast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun, 22: 361–366, 2001.

Tafra L. , Verbanac K.M. , Lannin D.R. : Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg, 182: 312–315, 2001.

Patel N.A. , Piper G. , Patel J.A. , Malay M.B. , Julian T.B. : Accurate axillary nodal staging can be achieved after neoadjuvant therapy for locally advanced breast cancer. Am Surg, 70: 696–699, 2004.

Breslin T.M. , Cohen L. , Sahin A. , Fleming J.B. , Querer H.M. , Newman L.A. , Delpassand E.S. , House R. , Ames F.C. , Feig B.W. , Ross M.I. , Singletary S.E. , Buzdar A.U. , Hortobagyi G.N. , Hunt K.K. : Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol, 18: 3480–3486, 2000.

Haid A. , Tausch C. , Lang A. , Lutz J. , Fritzsche H. , Peschina W. , Breitfellner G. , Sega W. , Aufschnaiter M. , Sturn H. , Zimmerman G. : Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer, 92: 1080–1084, 2001.

Stearns V. , Ewing A. , Slack R. , Penannen M.F. , Hayes D.F. , Tsangaris T.N. : Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol, 9: 235–242, 2002.

Brady E.W. : Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J, 8: 97–100, 2002.

Miller A.R. , Thomason J.E. , Yeh I.T. , Alrahwan A. , Sharkey F.E. , Stauffer J. , Otto P.M. , McKay C. , Kahlenberg M.S. , Phillips W.T. , Cruz A.B. : Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma. Ann Surg Oncol, 9: 243–247, 2002.

Julian T.B. , Dusi D. , Wolmark N. : Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg, 184: 315–317, 2002.

Sabel M.S. , Schott A.F. , Kleer C.G. , Merajver S. , Cimmino V.M. , Diehl K.M. , Hayes D.F. , Chang A.E. , Pierce L.J. : Sentinel node biopsy prior to neoadjuvant chemotherapy. Am J Surg, 186: 102–105, 2003.

Zirngibl C. , Steinfeld-Birg D. , Voght H. , Wagner T. , Wischnik A. : Sentinel lymph node biopsy before neoadjuvant chemotherapy - conservation of breast and axilla. San Antonio Breast Cancer Symposium. 2002. San Antonio, Texas; December 13(abstract 516).

Schrenk P. , Hochreiner G. , Fridrik M. , Wayand W. : Sentinel node biopsy performed before preoperative chemotherapy for axillary lymph node staging in breast cancer. Breast J, 9: 282–287, 2003.

Reitsamer R. , Peintinger F. , Rettehbacher L. , Prokop E. : Sentinel lymph node biopsy in breast cancer patients after neodjuvant chemotherapy. J Surg Oncol, 84: 63–67, 2003.

Schwartz G.F. , Meltzer A.J. Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J, 9: 374–379, 2003.

Balch G.C. , Mithani S.K. , Richards K.R. , Beauchamp R.D. , Kelley M.C. : Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol, 10: 616–621, 2003.

Piato J.R. , Barros A.C. , Pincerato K.M. , Sampaio A.P. , Pinotti J.A. : Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy: a pilot study. Eur J Surg Oncol, 29: 118–120, 2003.

Aihara T. , Munakata S. , Morino H. , Takatsuka Y. : Feasibility of sentinel lymph node biopsy for breast cancer after neoadjuvant endocrine therapy: a pilot study. J Surg Oncol, 85: 77–81, 2004.

Bonardi S. , Bottini A. , Brizzi M.P. , Allevi G. , Aguggini S. , Generali D. , Fringuelli F.M. , Bersiga A. , Iacona B. , Milani M. , Lima G.F. , Berruti A. , Dogliotti L. : Role of sentinel lymph node mapping in human breast cancer after primary chemotherapy. Proceedings of the 27th Annual San Antonio Breast Cancer Symposium, 2004; San Antonio, TX, (abstract). http://www.abstracts2view.com/sabcs/index.php [January 2005].

Kang S.H. , Kim S.K. , Kwon Y. , Kang H.S. , Kang J.H. , Ro J. , Lee E.S. : Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy. World J Surg, 28: 1019–1024, 2004.

Shimazu K. , Tamaki Y. , Taguchi T. , Akazawa K. , Inoue T. , Noguchi S. : Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma. Cancer, 100: 2555–2561, 2004.

Lang J.E. , Esserman L.J. , Ewing C.A. , Rugo H.S. , Lane K.T. , Leong S.P. , Hwang E.S. : Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. J Am Coll Surg, 199: 856–862, 2004.

Tio J. , Behner M. , Wulfing P. , Parchent H. , Volkholz H. , Schulze W. , Uta E. , Tulusan A.H. : Sentinel lymph node biopsy after primary systemic treatment of locally advanced breast cancer. Proceedings of the 27th Annual San Antonio Breast Cancer Symposium, 2004; San Antonio, TX, (abstract). http://www.abstracts2view.com/sabcs/index.php [January 2005].

Khan A. , Sabel M.S. , Nees A. , Diehl K.M. , Cimmino V.M. , Kleere C.G. , Schott A.F. , Hayes D.F. , Chang A.E. , Newman L.A. : Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node bioppsy. Ann Surg Oncol, 12: 697–704, 2005.

Mamounas E.P. , Brown A. , Anderson S. , Smith R. , Julian T. , Miller B. , Bear H.D. , Caldwell C.B. , Walker A.P. , Mikkelson W.M. , Stauffer J.S. , Robidoux A. , Theoret H. , Soran A. , Fisher B. , Wickerham D.L. , Wolmark N. : Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol, 23: 2694–2702, 2005.

Jones J.L. , Zabicki K. , Christian R.L. , Gadd M.A. , Hughes K.S. , Lesnikaski B.A. , Rhei E. , Specht M.C. , Dominguez F.J. , Smith B.L. : A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Am J Surg, 190: 517–520, 2005.

Olilla D.W. , Neuman H.B. , Sartor C. , Carey L.A. , Klauber-Demore N. : Lymphatic mapping and sentinel lymphadenectomy prior to neoadjuvant chemotherapy in patients with large breast cancer. Am J Surg, 190; 371–375, 2005.

van Rijk M.C. , Nieweg O.E. , Rutgers E.J. , Oldenburg H.S. , Olmos R.V. , Hoefnagel C.A. , Kroon B.B. : Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection. Ann Surg Oncol, 13: 475–479, 2006.

Cox C.E. , Cox J.M. , White L.B. , Stowell N.G. , Clark J.D. , Allred N. , Meyers M. , Dupont E. , Furman B. , Minton S. : Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer. Ann Surg Oncol, 13: 483–490, 2006.

Tanaka Y. , Maeda H. , Ogawa Y. , Nishioka A. , Itoh S. , Kubota K. , Ue H. , Nakatani K. , Sasaguri S. : Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Oncol Rep, 15: 927–931, 2006.

Peley G. , Torok K. , Farkas E. , Matrai Z. , Horvath Z. , Sinkovics I. , Hitre E. , Renyi-Varnos F. , Orosz Z. , Koves I. : The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer. Magy Onkol, 50: 19–23, 2006.

Lee S. , Kim E.Y. , Kang S.H. , Kim S.W. , Kim S.K. , Kang K.W. , Kwon Y. , Shin K.H. , Kang H.S. , Ro J. , Lee E.S. : Sentinel node identification rate, but not accuracy, is significantly decreased after preoperative chemotherapy in axillary node-positive breast cancer patients. Breast Cancer Res Treat, 102: 283–288, 2007.

Kinoshita T. : Sentinel lymph node biopsy in feasible for breast cancer patients after neoadjuvant chemotherapy. Breast Cancer, 14: 10–15, 2007.

Shen J. , Gilcrease M.Z. , Babiera G.V. , Ross M.I. , Meric-Bernstam F. , Feig B.W. , Querer H.M. , Francis A. , Ames F.C. , Hunt K.K. : Feasibility and accuracy of sentinel node biopsy alter preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer, 109: 1255–1263, 2007.

Newman E.A. , Sabel M.S. , Nees A.V. , Schott A. , Diehl K.M. , Cimmino V.M. , Chang A.E. , Kleer C. , Hayes D.F. , Newman L.A. : Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol, 14: 2946–2952, 2007.

Bauerfeind I. , Kuehn T. , Hoess C. : A multicentric analysis and an introduction of a German prospective study to evaluate the value of sentinel node excision after neoadjuvant chemotherapy. Eur J Cancer 6 (suppl): 148 (abstract 336), 2008.

Reitsamer R. , Glueck S. , Schlederer E. : The accuracy of sentinel node biopsy after primary systemic therapy is comparable with the results of sentinel node biopsy in breast cancer patients with primary surgery. Eur J Cancer 6 (suppl): 150 (abstract 345), 2008.

Gimbergues P. , Abrial C. , Durando X. , Le Bouedec G. , Cachin F. , Penault-Llorca F. , Mouret-Reynier M.A. , Kwiatkowski F. , Maublant J. , Tchirkov A. , Dauplat J. : Sentinel lymph node biopsy alter neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Ann Surg Oncol, 15: 1316–1321, 2008.

Grube B.J. , Christy C.J. , Black D. , Martel M. , Harris L. , Weidhaar J. , Digiovanna M.P. , Chung G. , Abu-Khalaf M.M. , Miller K.D. , Higgins S.A. , Philpotts L. , Tavassoli F.A. , Lannin D.R. : Biopsy sentinel lymph node dissection before preoperative chemotherapy. Arch Surg, 143: 692–699, 2008.

Papa M.Z. , Zippel D. , Kaufman B. , Shimon-Paluch S. , Yosepovich A. , Oberman B. , Sadetzki S. : Timing of sentinel lymph node in patients receiving neoadjuvant chemotherapy for breast cancer. J Surg Oncol, 98: 403–406, 2008.

Gomez R.E. , Zakhirch J. , Moore D. , De Michele A. , Przewoznik J. , Olilla D. , Frank J. , Krontiras H. , Montgomery L. , Sarode V. , Broadwater G. , Esserman L. : Sentinel lymph node biopsy performed in the neoadjuvant setting for breast cancer: results from the I-SPY TRIAL. Proceedings of the 31^st Annual San Antonio Breast Cancer Symposium, 2008. Cancer Res, 69(suppl): 85s (abstract 202), 2009.

Wishart G.C. , Benson J.R. , Absar M.S. , Vallier A.L. , Hiller L. , Fenwick N. , Champ R. , Provenzano E. , Caldos C. , Earl H.M. : Sentinel lymph node biopsy prior to chemotherapy in breast cancer patients. Proceedings of the 31^st Annual San Antonio Breast Cancer Symposium, 2008. Cancer Res, 69(suppl): 342s (abstract 5111), 2009.

Xing Y. , Foy M. , Cox D.D. , Kuerer H.M. , Hunt K.K. , Cormier J.N. : Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg, 93: 539–546, 2006.

Lerman H. , Matser U. , Lievshitz G. , Sperber F. , Shneebaum S. , Even-Sapir E. : Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT. Eur J Nucl Med Mol Imaging, 33: 329–337, 2006.

Neuman H. , Carey L.A. , Ollila D.W. , Livasy C. , Calvo B.F. , Meyer A.A. , Kim H.J. , Meyers M.O. , Dees E.C. , Collichio F.A. , Sartor C.I. , Moore D.T. , Sawyer L.R. , Frank J. , Klauber-DeMore N. : Axillary lymph node count is lower after neoadjuvant chemotherapy. Am J Surg, 191: 827–829, 2006.

Straver M.E. , Rutgers E.J. , Oldenburg H.S. , Wesseling J. , Linn S.C. , Russell N.S. , Vrancken Peeters M.J. : Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapy. Am J Surg, 198: 46–50, 2009.

Bedrosian I. , Reynolds C. , Mick R. , Callans L.S. , Grant C.S. , Donohue J.H. , Farley D.R. , Heller R. , Conant E. , Orel S.G. , Lawton T. , Fraker D.L. , Czerniecki B.J. : Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer, 88: 2540–2545, 2000.